Nuclear stress tests are among the safest cardiac imaging procedures in routine use, with serious complications occurring in well under one percent of cases. The test works by tracking blood flow through the heart muscle during exertion or simulated exertion, and the radiation dose involved is comparable to a few years of natural background exposure. That said, “safe” does not mean “risk-free,” and the details matter depending on which stress agent you receive, which radiotracer is used, and whether you fall into a population where the test behaves differently than expected.
What the Test Actually Does
A nuclear stress test, formally called myocardial perfusion imaging (MPI), captures pictures of blood flowing through your heart at rest and under stress. A small amount of radioactive tracer is injected into a vein, travels through the bloodstream, and is taken up by heart muscle cells in proportion to how much blood they receive. A special camera then detects the gamma rays the tracer emits and builds a map of perfusion across the heart wall. Areas that light up normally at rest but go dark under stress suggest a coronary artery blockage limiting flow when the heart works harder.1Journal of Nuclear Medicine. Nuclear Cardiac Stress Testing in the Era of Molecular Medicine
The “stress” part can come from exercise on a treadmill or stationary bike, or from a drug that mimics the cardiovascular effects of exercise. Most people prefer the treadmill because it feels intuitive, but if you cannot exercise adequately because of arthritis, lung disease, deconditioning, or other limitations, a pharmacologic agent is substituted. The choice between exercise and pharmacologic stress has real implications for your side-effect profile, which we will get into below.
How Much Radiation Are You Getting?
Radiation is the concern most patients raise first, and the numbers are worth putting in perspective. The dose from a nuclear stress test generally falls between about 4 and 10 millisieverts (mSv), though it varies by the specific tracer and protocol used. For comparison, you absorb roughly 3 mSv per year just from natural background sources like radon, cosmic rays, and the ground beneath your feet. So a nuclear stress test delivers somewhere between one and three years’ worth of background radiation in a single session.
Not all tracers are equal on this front. Older dual-isotope protocols that combine thallium-201 with technetium-99m deliver the highest doses. In contrast, newer PET tracers such as nitrogen-13 ammonia sit at the low end of the range. A study modeling cancer risk across the full spectrum of MPI protocols found that the estimated risk for a scan performed at age 50 ranged from about 2 future cancers per 10,000 scans with low-dose PET ammonia to 25 per 10,000 scans with the old dual-isotope approach.2PubMed Central. Myocardial perfusion scans: projected population cancer risks from current levels of use in the U.S That is a tenfold difference depending purely on protocol choice, and it underscores why many labs have moved away from thallium-based protocols.
Those numbers sound alarming until you consider two things. First, they are projections extrapolated from radiation models, not directly observed cancer cases. The risk estimates borrow heavily from data on atomic bomb survivors and are then scaled down to the much lower doses used in medical imaging, an approach that introduces substantial uncertainty.3PubMed Central. Effects of radiation exposure from cardiac imaging: how good are the data? Second, the people receiving these scans usually have suspected or known coronary artery disease, a condition that kills hundreds of thousands of Americans each year. Missing a significant blockage carries its own risk, and a normal perfusion scan provides strong reassurance that your near-term cardiac outlook is favorable.
The Stress Drug You Receive Matters
If you cannot exercise on a treadmill, a pharmacologic stress agent is used instead. The two main categories are vasodilators, which widen your coronary arteries to simulate increased flow, and inotropes like dobutamine, which directly speed up your heart. Each comes with a distinct side-effect fingerprint.
Vasodilator Agents
The most commonly used vasodilators today are regadenoson (brand name Lexiscan), adenosine, and dipyridamole. All three work by activating adenosine receptors in the coronary arteries, but they differ in how selectively they hit the intended target. Adenosine and dipyridamole activate multiple adenosine receptor subtypes, and the off-target receptors are responsible for most of the unpleasant side effects: flushing, headache, chest tightness, and shortness of breath.4Journal of Nuclear Medicine Technology. Advances in Pharmacologic Stress Agents: Focus on Regadenoson Regadenoson was designed to be more selective for the A2A receptor subtype that produces the desired coronary vasodilation, and it was expected to cause fewer side effects.
In practice, the picture is more complicated. A study comparing adenosine and regadenoson in outpatient stress testing found that a higher proportion of patients given regadenoson experienced at least one side effect compared with those given adenosine: about 80% versus 32%. Regadenoson was associated with more arrhythmias, more shortness of breath, and more headache, and patients receiving it were far more likely to need aminophylline, the rescue drug used to reverse vasodilator effects.5PubMed. Comparison of the Safety of Adenosine and Regadenoson in Patients Undergoing Outpatient Cardiac Stress Testing Despite this, regadenoson remains popular because it is given as a single quick injection rather than a continuous infusion, which simplifies the workflow considerably.6PubMed Central. Regadenoson Stress Testing: A Comprehensive Review With a Focused Update
The reassuring part is that nearly all vasodilator side effects are short-lived. They typically resolve within minutes after the infusion stops or after aminophylline is administered. Life-threatening events during vasodilator stress are extremely rare.
Dobutamine
Dobutamine is reserved for patients who cannot receive vasodilators, often because of significant asthma or chronic obstructive pulmonary disease (COPD). It works differently: instead of dilating the coronary arteries, it directly stimulates the heart to beat faster and harder, mimicking the effect of physical exercise. This catecholamine-like action carries a somewhat higher risk of cardiac arrhythmias.
In a series of over 3,000 dobutamine stress studies, the protocol had to be stopped early in about 8% of patients because of side effects, most commonly a drop in blood pressure or obstruction of blood flow leaving the heart. Serious complications occurred in nine patients across the entire series, including sustained ventricular tachycardia in five and a heart attack in one, but there were no deaths.7PubMed. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years Another series of 1,000 high-dose dobutamine stress procedures reported sustained ventricular tachycardia in one patient, non-sustained ventricular tachycardia in four, and new atrial fibrillation in 16.8European Heart Journal. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases
Overall, life-threatening complications with dobutamine are estimated at roughly 0.04% for ventricular fibrillation, 0.15% for sustained ventricular tachycardia, and 0.02% for heart attack. Death is exceedingly rare, under 0.01%.9Frontiers in Cardiovascular Medicine. Complications of exercise and pharmacologic stress echocardiography These numbers are higher than for vasodilator stress, which is why dobutamine is used only when vasodilators are not appropriate.
Exercise Stress Versus Drug Stress
When you can walk on a treadmill, exercise stress is generally preferred. It produces more physiologically natural hemodynamic changes and gives the physician additional information from your exercise capacity and ECG response during exertion. It also tends to cause fewer bothersome side effects than pharmacologic agents.
A comparison of pure pharmacologic stress versus combined exercise-plus-drug protocols found that adding even a small amount of walking to a vasodilator infusion reduced the frequency of chest discomfort, flushing, drops in blood pressure, and episodes of sinus bradycardia (slow heart rate). Among younger patients receiving adenosine, for example, atrioventricular block occurred roughly half as often when exercise was combined with the drug compared with the drug alone.10Journal of Nuclear Cardiology. Complications of exercise and pharmacologic stress tests: Differences in younger and elderly patients No patient in either the exercise or pharmacologic groups experienced life-threatening complications in that study.
If you are offered the choice between treadmill and pharmacologic testing, and you are physically able to reach an adequate heart rate on the treadmill, the exercise option generally produces a cleaner experience with fewer side effects.
Lungs, Breathing, and Vasodilator Caution
One population that warrants special mention is people with asthma or COPD. Adenosine and dipyridamole can provoke bronchoconstriction, meaning they may trigger wheezing or worsened shortness of breath in susceptible individuals. This was a well-known concern even in the early days of pharmacologic stress testing.11PubMed Central. Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge Regadenoson’s more selective receptor profile was expected to ease this risk, and clinical experience suggests it is tolerated better in patients with mild to moderate airway disease. However, most labs still default to dobutamine for patients with severe or poorly controlled obstructive lung disease, accepting the cardiac arrhythmia trade-off in exchange for avoiding a bronchospasm event.
Pregnancy, Breastfeeding, and Radiation Considerations
Nuclear stress tests are rarely performed during pregnancy because the developing fetus is more sensitive to radiation than an adult. When imaging is medically necessary, physicians generally exhaust non-radioactive alternatives first, such as exercise echocardiography or cardiac MRI, before considering nuclear tracers.
Breastfeeding mothers face a more navigable situation. The radiotracers used in cardiac imaging do get excreted into breast milk, which means a nursing infant could receive an unnecessary radiation dose. The specific interruption period depends entirely on which tracer was used. For most technetium-99m compounds, no breastfeeding interruption is needed. For technetium-99m pertechnetate, red blood cell, or MAA preparations, a 12-hour pause is recommended. For thallium-201, the recommended suspension is 48 hours.12Radiation Protection Dosimetry. X-RAY AND MOLECULAR IMAGING DURING PREGNANCY AND BREASTFEEDING—WHEN SHOULD WE BE WORRIED? These timelines are calibrated to keep the infant’s dose below 1 mSv. Many mothers are advised to pump and store milk before the test so feeding can continue uninterrupted, with the post-tracer milk being discarded during the suspension window.13Seminars in Nuclear Medicine. Radiation Dose Concerns for the Pregnant or Lactating Patient
Why Caffeine Can Wreck Your Results
If you have ever been told to skip your morning coffee before a nuclear stress test, there is a real reason behind it. Caffeine is a direct antagonist of adenosine receptors. Since vasodilator stress agents like regadenoson work precisely by activating those receptors, caffeine in your system can blunt the drug’s effect and mask genuine perfusion defects.
A prospective multicenter trial tested this head-on by giving patients either 200 mg of caffeine (roughly the amount in a strong cup of drip coffee), 400 mg, or placebo before a regadenoson stress test. Both caffeine doses significantly reduced the number of heart segments showing reversible perfusion defects. Among patients with moderate ischemia, about 72% who received caffeine were reclassified as non-ischemic, meaning their real blockages were hidden.10Journal of Nuclear Cardiology. Complications of exercise and pharmacologic stress tests: Differences in younger and elderly patients This is not a side effect in the usual sense, but it is arguably the most consequential preparation failure: a false-negative result could lead to a dangerous blockage going undetected. Most labs ask you to avoid caffeine for at least 12 to 24 hours before a vasodilator stress test.
False Positives and Body Habitus
The opposite problem, a false-positive result, is also worth understanding. Nuclear perfusion images can appear abnormal even when the coronary arteries are perfectly healthy, a phenomenon driven by attenuation artifacts. Soft tissue between the heart and the camera absorbs some gamma rays, creating shadows that mimic perfusion defects. This is a recognized issue in obese patients and in women with large breasts, where tissue attenuation is more pronounced.14PubMed Central. Is cardiac MRI stress imaging a cost-saving strategy for obese patients?
A false-positive result is not dangerous in itself, but it can lead to an unnecessary coronary angiogram, an invasive catheter-based procedure that carries its own small risk of vascular injury, bleeding, and radiation exposure. For patients in whom attenuation artifacts are likely, labs may use attenuation correction software, prone imaging (lying face-down for a second set of images), or recommend cardiac MRI stress testing as an alternative that avoids the issue entirely.
Newer Technology Is Cutting the Dose
One of the most meaningful safety improvements in recent years has come from camera technology rather than drug development. Traditional gamma cameras use sodium iodide crystals to detect the tracer’s emissions. A newer generation of cameras built with cadmium-zinc-telluride (CZT) semiconductor detectors are substantially more sensitive, meaning they can produce equivalent image quality with less tracer and shorter scan times.
In one evaluation, a CZT camera paired with a low-dose technetium-99m protocol delivered an effective dose of about 5.8 mSv, roughly half the dose of a conventional technetium study and about 76% less than a traditional dual-isotope protocol. Image quality and diagnostic accuracy were maintained, and patients with normal perfusion had a benign prognosis at 12-month follow-up.15PubMed. Reduced isotope dose and imaging time with a high-efficiency CZT SPECT camera Another group demonstrated that a stress-first protocol on a CZT camera maintained high diagnostic accuracy while dramatically reducing the average patient dose, particularly in lower-risk populations where a normal stress image meant the rest scan could be skipped altogether.16PubMed. Stress-first protocol for myocardial perfusion SPECT imaging with semiconductor cameras: high diagnostic performances with significant reduction in patient radiation doses
These hardware and protocol innovations mean that the dose figures you see quoted in older literature may overstate what you would actually receive at a modern lab. If radiation exposure is a concern for you, it is reasonable to ask whether your facility uses CZT cameras and stress-first protocols.
Anxiety, Claustrophobia, and the Patient Experience
Safety discussions tend to focus on radiation and cardiac complications, but the lived experience of the test matters too. You spend time lying still under a large camera that rotates close to your body, which can trigger claustrophobia. The pharmacologic agents can produce unsettling sensations: regadenoson commonly causes a feeling of breathlessness and chest heaviness that patients sometimes mistake for a heart attack, and dobutamine makes the heart pound in a way that feels alarming even when it is medically benign.
Anxiety levels during nuclear medicine procedures can be substantial, particularly in younger patients and those with a history of claustrophobia. A randomized trial in a pediatric nuclear medicine setting found that virtual reality distraction reduced anxiety scores by roughly 43% compared with standard care, and claustrophobia was independently associated with higher anxiety even after adjustment.17Research Square. Effectiveness of a Virtual Reality-Based Intervention to Reduce Anxiety and Pain in Pediatric Nuclear Medicine: A Randomized Clinical Trial Adult labs have been slower to adopt distraction tools, but the finding highlights how much of the discomfort people report after a nuclear stress test is psychological rather than pharmacological. If you know you are prone to claustrophobia or medical anxiety, mentioning it ahead of time lets the technologist adjust camera positioning and talk you through what each sensation means as it happens.
Which Tracer Carries the Least Risk
The original workhorse tracer, thallium-201, has been gradually displaced for good reason. Its physical properties produce lower image quality and a higher radiation dose compared with technetium-99m agents. Technetium-99m sestamibi, the most widely used tracer today, allows higher injected activities with better image quality and lower effective doses because technetium-99m emits gamma rays at an energy that cameras detect more efficiently, and it leaves the body faster.18American Journal of Cardiology. Myocardial perfusion imaging with thallium-201, new technetium-99m agents, and positron emission tomography
PET tracers like rubidium-82 and nitrogen-13 ammonia sit at the lowest end of the dose spectrum. PET imaging also provides better spatial resolution, and some protocols can quantify absolute blood flow rather than just showing relative differences, which adds diagnostic value. The trade-off is that PET scanners are not available everywhere, and rubidium-82 requires an on-site generator that adds cost. Still, if your hospital offers PET perfusion imaging and your insurance covers it, the combination of lower radiation and better diagnostic precision makes it an appealing option.
For the roughly 9 million myocardial perfusion scans performed annually in the United States, population-level modeling has estimated that these scans could lead to about 7,400 additional future cancers, though the uncertainty interval is wide, ranging from 3,300 to 13,700.2PubMed Central. Myocardial perfusion scans: projected population cancer risks from current levels of use in the U.S Spread across millions of tests, that translates to less than one additional cancer per thousand scans on average, and the risk falls further at older ages, roughly halving by age 70. Given that the test is most commonly performed in middle-aged and older adults already at elevated cardiac risk, the calculus almost always favors testing when a physician has a genuine clinical indication.